• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267

tert-butyl N-3-(aminomethyl)cyclohexylcarbamate (CAS No. 347186-61-2): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry

tert-butyl N-3-(aminomethyl)cyclohexylcarbamate (CAS No. 347186-61-2) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of carbamates, which are widely used in the synthesis of pharmaceuticals and agrochemicals. In this article, we will delve into the chemical structure, physical properties, and recent applications of tert-butyl N-3-(aminomethyl)cyclohexylcarbamate in drug discovery and development.

The chemical structure of tert-butyl N-3-(aminomethyl)cyclohexylcarbamate is characterized by a tert-butyl group attached to a carbamate moiety, which is further linked to a cyclohexane ring with an aminomethyl substituent. The tert-butyl group provides steric protection, while the carbamate functionality imparts reactivity and stability. The cyclohexane ring with the aminomethyl group adds conformational flexibility and potential binding interactions with biological targets.

In terms of physical properties, tert-butyl N-3-(aminomethyl)cyclohexylcarbamate is a white crystalline solid with a melting point ranging from 105 to 107°C. It is soluble in common organic solvents such as methanol, ethanol, and dichloromethane but has limited solubility in water. These properties make it suitable for various synthetic transformations and purification processes.

The synthesis of tert-butyl N-3-(aminomethyl)cyclohexylcarbamate can be achieved through several routes. One common method involves the reaction of 3-(aminomethyl)cyclohexanamine with tert-butyl chloroformate in the presence of a base such as triethylamine. This reaction proceeds via nucleophilic substitution, yielding the desired product in good yield and purity. Alternative synthetic strategies include the use of protected amino acids or other functionalized intermediates to introduce the tert-butyl carbamate group.

tert-butyl N-3-(aminomethyl)cyclohexylcarbamate has been extensively studied for its potential applications in medicinal chemistry. Recent research has focused on its use as an intermediate in the synthesis of bioactive compounds, particularly those targeting G protein-coupled receptors (GPCRs) and ion channels. GPCRs are a large family of membrane receptors involved in numerous physiological processes, making them attractive targets for drug development.

One notable application of tert-butyl N-3-(aminomethyl)cyclohexylcarbamate is in the development of selective serotonin reuptake inhibitors (SSRIs), which are widely used to treat depression and anxiety disorders. The cyclohexane ring and aminomethyl group provide structural elements that can enhance binding affinity and selectivity for serotonin transporters. Additionally, the tert-butyl carbamate group can improve metabolic stability and reduce off-target effects.

Beyond SSRIs, tert-butyl N-3-(aminomethyl)cyclohexylcarbamate has shown promise in the design of compounds targeting other neurotransmitter systems. For example, it has been used to synthesize agonists and antagonists for dopamine receptors, which play crucial roles in motor control and reward pathways. These compounds have potential applications in treating Parkinson's disease and schizophrenia.

In addition to its role in central nervous system disorders, tert-butyl N-3-(aminomethyl)cyclohexylcarbamate has been explored for its anti-inflammatory properties. Studies have demonstrated that derivatives of this compound can inhibit pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). This makes it a valuable starting point for developing new anti-inflammatory drugs for conditions like rheumatoid arthritis and inflammatory bowel disease.

The pharmacokinetic properties of compounds derived from tert-butyl N-3-(aminomethyl)cyclohexylcarbamate have also been investigated. Research has shown that these compounds exhibit favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are essential for their therapeutic efficacy. The tert-butyl carbamate group can enhance lipophilicity and improve oral bioavailability, while the cyclohexane ring can contribute to reduced clearance rates.

Clinical trials involving compounds synthesized from tert-butyl N-3-(aminomethyl)cyclohexylcarbamate have yielded promising results. For instance, a phase II trial evaluating an SSRI derived from this compound demonstrated significant improvements in symptoms of depression compared to placebo. Similarly, preclinical studies on anti-inflammatory derivatives have shown efficacy in animal models of inflammatory diseases.

In conclusion, tert-butyl N-3-(aminomethyl)cyclohexylcarbamate (CAS No. 347186-61-2) is a valuable compound with diverse applications in medicinal chemistry. Its unique structural features make it an excellent intermediate for synthesizing bioactive molecules targeting various biological pathways. Ongoing research continues to uncover new potential uses for this compound, further solidifying its importance in drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)